Helping young adults with type 1 diabetes manage their health during the transition to adulthood
Improving Transition Care for Adolescents and Young Adults with Type 1 Diabetes: A Randomized Controlled Trial of SHIFT2
This study is looking to help young people with type 1 diabetes, ages 16 to 22, manage their condition better as they move into adulthood by offering them a special program that teaches important self-care skills and provides support, compared to regular care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Virginia Commonwealth University NIH-funded |
| Lab location | 1 site (Richmond, United States) |
| Project ID | NIH-11098468 on NIH RePORTER |
What this research studies
This research focuses on improving the management of type 1 diabetes (T1D) for adolescents and young adults as they transition into adulthood, a critical period often marked by challenges in maintaining glycemic control. The study will involve a randomized controlled trial where participants aged 16-22 will receive either a comprehensive transition preparation program or standard care. The intervention, known as SHIFT2, aims to enhance self-management skills and readiness for adult healthcare through a combination of clinic visits and technology-based support. By addressing the unique needs of this age group, the research seeks to provide tailored support during a pivotal time in their lives.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 16 to 22 who have been diagnosed with type 1 diabetes.
Not a fit: Patients outside the age range of 16 to 22 or those without a diagnosis of type 1 diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diabetes management and better health outcomes for young adults transitioning to adult care.
How similar studies have performed: Previous studies have shown promise in using structured transition programs for chronic conditions, indicating potential success for this approach in type 1 diabetes management.
Where this research is happening
Richmond, United States
- Virginia Commonwealth University — Richmond, United States (Active)
Researchers
- Principal investigator: Caccavale, Laura Jean — Virginia Commonwealth University
- Study coordinator: Caccavale, Laura Jean
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.